Angiotensin receptor‐neprilysin inhibitors in concurrent heart failure with reduced ejection fraction and kidney failure

Abstract Aims Angiotensin receptor‐neprilysin inhibitor (ARNI) therapy has demonstrated improved outcomes in heart failure with reduced ejection fraction (HFrEF). However, its benefits in patients with concomitant kidney failure undergoing replacement therapy remain uncertain. Methods and results Us...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Mi‐Hyang Jung, Dong‐Hyuk Cho, Jimi Choi, Mi‐Na Kim, Chan Joo Lee, Jung‐Woo Son, Yaeni Kim, Jong‐Chan Youn, Byung‐Su Yoo
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Wiley 2025-10-01
Reeks:ESC Heart Failure
Onderwerpen:
Heart failure, systolic
Hospitalization
Kidney failure, chronic
Mortality
Renin‐angiotensin system
Treatment outcome
Online toegang:https://doi.org/10.1002/ehf2.15359
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items